Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.71 USD | +1.21% | +1.51% | -26.43% |
Mar. 20 | Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing | MT |
Mar. 19 | Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.43% | 878M | |
+9.50% | 222B | |
+7.95% | 185B | |
+18.30% | 141B | |
+18.47% | 100B | |
+7.83% | 68.36B | |
+25.32% | 57.52B | |
-3.15% | 46.84B | |
+4.66% | 42.64B | |
+17.58% | 41.4B |
- Stock
- Equities
- Stock Cytek Biosciences, Inc. - Nasdaq
- News Cytek Biosciences, Inc.
- Transcript : Cytek Biosciences, Inc., Q1 2022 Earnings Call, May 11, 2022